Beginning Stock Price. (i) Beginning Stock Price shall mean the average of the Daily Averages for each of the twenty (20) trading days immediately prior to the first day of the Performance Period;
Beginning Stock Price. The beginning and ending stock prices in the above formula for TSR will be calculated using a trailing average approach (i.e., average of the closing stock prices for 20 consecutive trading days prior to the beginning and end of the Performance Period). The above TSR formula assumes that dividends are paid and reinvested into additional shares of common stock on their ex-dividend dates. TSR will be adjusted for stock dividends, stock splits, spin-offs and other corporate changes having a similar effect. The percentile performance for determining the TSR Percentile Rank will be measured using the Microsoft Excel function PERCENTRANK.
Beginning Stock Price. The stock prices and cash dividend payments reflected in the calculation of Total Shareholder Return shall be adjusted to reflect stock splits during the Performance Period, and dividends shall be assumed to be reinvested in the relevant issuer’s shares for purposes of the calculation of Total Shareholder Return.
Beginning Stock Price. In all events, TSR shall be adjusted to give effect to any stock dividends, stock splits, reverse stock splits and similar transactions.
Beginning Stock Price. The Ending Stock Price shall equal the average daily-closing stock price of the twenty trading days preceding December 31, 2023. The Beginning Stock Price shall equal the average daily-closing stock price of the twenty trading days preceding January 1, 2021. Paid Dividends shall represent the value of dividends for which the ex-dividend date occurs during the Performance Period, and, for purposes of the TSR calculation, dividends are assumed to be reinvested in additional shares of stock as of the ex-dividend date. The Company’s TSR calculated as described above shall be compared to the TSR calculated in the same manner for the Xxxxxxx 2000 companies.
Beginning Stock Price. Where “Beginning Stock Price” means the daily average closing price of one share of common stock for the twenty trading days prior to the first day of the Performance Period; Where “Ending Stock Price” means the daily average closing price of one share of common stock for the twenty-trading day prior to and including the last day of the Performance Period; Where “Dividends” means the total of all cash dividends paid on one share of common stock during the Performance Period, assumed to be reinvested in additional shares of common stock on the ex-dividend date. 5.
Beginning Stock Price. Beginning Stock Price shall mean the average closing price on the applicable stock exchange of one share of stock for all the trading days in the fiscal month immediately following the beginning of the Company’s fiscal year which is the start of the Performance Period; Ending Stock Price shall mean the average closing price on the applicable stock exchange of one share of stock for all the trading days in the fiscal month immediately prior to the last day of the Performance Period, and Dividends Paid shall mean the total of all dividends paid on one (1) share of stock during the Performance Period; provided that, dividends shall be treated as though they are reinvested at the end of each calendar quarter. Following the Total Shareholder Return determination, the Company’s Percentile Rank shall be determined as follows: Percentile Rank Company Rank = Total number of companies in Performance Group including the Company Company Rank shall be determined by listing from highest TSR to lowest TSR of each company in the Performance Group (including the Company) and counting up from the company with the lowest TSR.
Beginning Stock Price. The beginning stock price will be determined using the 20-trading day average closing stock price ending on the first day of the performance period.
Beginning Stock Price. Beginning Price = Average closing stock price for the 90 trading days preceding the start of the performance period • Ending Price = Average closing stock price for the last 90 trading days of the performance period • Reinvested Dividends = Dividends are assumed to be reinvested as of the ex-dividend date in the calculation 2024 Proxy Peer Group Alight Genpact LTD CACI International ICF Intl CGI Group Leidos Holdings, Inc. Concentrix Maximus, Inc. CSG Systems Intl TELUS Intl ExlService TriNet Group Veradigm (formerly Allscripts) • Acquired peers (not the surviving company) will be removed from peer group for measurement. • Bankrupt peers will be forced rank to the bottom (assume -100% TSR). • Peer spins off business--keep peer and include in SpinCo distribution/dividend in calculation of the peer's TSR. EXHIBIT B Non-Competition and Non-Solicitation Agreement This Non-Competition and Non-Solicitation Agreement (“Agreement”) is made effective as of April 1, 2024 (“Effective Date”) between Conduent Business Services, LLC, its parent, subsidiaries, divisions and affiliates (collectively, “Conduent”) and the individual whose name appears in the Award Summary (“Employee”).
Beginning Stock Price. Comparator Group All companies in the S&P 6-Digit GICS code for Healthcare Equipment and Supplies with revenue > $500M for most recent fiscal year. Performance / Payout Scale The TSR for all members of the comparator group at the end of the period will be calculated and each member will then be ranked. Payout will be calculated using: • Threshold: 25th percentile = 50% of shares • 50th percentile = 100% of shares • 75th percentile = 200% of shares Linear interpolation between 25th and 75th percentile Performance Period 3 year with stock price equal to the average of the closing price of the first 30 trading days (beginning 1/1/2019) and the closing price of the last 30 trading days (ending 12/31/2021) Negative TSR Plan pays at performance levels outlined above Comparator Group • Company is acquired Remove from peer group Adjustments • Company acquires (survivor) Remain in peer group • Bankruptcy Remain in peer group (until delisted from primary exchange or revenue falls below $500M) Exhibit 10.3 AVANOS MEDICAL, INC. CASH-SETTLED STOCK APPRECIATION RIGHT AWARD AGREEMENT AVANOS MEDICAL, INC., a Delaware corporation (hereinafter called the "Corporation"), has granted to the participant (the “Participant) named in the Notification of Grant Award provided on the Fidelity Investments (”Fidelity”) site, or any successor system (the “Grant Notice”) an award of cash-settled Stock Appreciation Rights equal to the difference between the Xxxxx Xxxxx and the Fair Market Value of the Common Stock on the date of conversion (the “Award”), pursuant to the terms set forth in the AVANOS MEDICAL, INC. 2021 Equity Participation Plan (the “Plan”) and this Award Agreement, including any country-specific terms and conditions contained in Appendix A to this Award Agreement. Capitalized terms used but not defined in this Award Agreement shall have the meanings specified in the Plan.
